Literature DB >> 31706017

Development of doxycycline hyclate suppositories and pharmacokinetic study in rabbits.

Ana Paula Christ1, Pauline Trindade Biscaino1, Rebeca Lino Lourenço2, Alieni Bitencourt de Souza2, Estevan Sonego Zimmermann1, Andréa Inês Horn Adams3.   

Abstract

Doxycycline hiclate is a broad spectrum antibiotic widely used in human and veterinary medicine. The inability to perform the parenteral administration of drugs and the lack of oral preparations can be mentioned as difficulties in the treatment of animals in the domestic environment. In this scenario, the aim of this study was to investigate the bioavailability of the drug by rectal route, to propose a potential suppository formulation containing 25 mg of doxycycline as an alternative to the available injectable formulations. Hydrophilic and lipophilic suppositories were prepared, in polyethylene glycol (S-PEG) or cocoa butter (S-CBT), respectively. The suppositories were prepared and evaluated concerning visual characteristics, content, average weight, melting range, content uniformity and in vitro release. A stability study was performed and the two most stable formulations were submitted to a pharmacokinetic study in rabbits. The bioavailability of the suppositories was compared to the data of the intravenous (i.v.) formulation. PEG suppository showed 49.13% bioavailability and CBT 51.43% with Cmax equal to 2.06 ± 2.96 µg.mL-1 and 1.54 ± 0.28 µg.mL-1, respectively. The data obtained suggest that rectal administration may become another method of administration of doxycycline in the treatment of bacterial infections.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Doxycycline; Pharmaceutical development; Pharmacokinetics; Rectal; Suppository; Veterinary

Mesh:

Substances:

Year:  2019        PMID: 31706017     DOI: 10.1016/j.ejps.2019.105141

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  2 in total

1.  Characterisation of rectal amoxicillin (RAMOX) for the treatment of pneumonia in children.

Authors:  Sara M Hanning; Silvia Matiz; Katharina Krasser; Mine Orlu; Cornelius Dodoo; Simon Gaisford; Catherine Tuleu
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

2.  Population Pharmacokinetic Modelling of Orally Administered Doxycycline to Rabbits at Different Ages.

Authors:  Rositsa Mileva; Anton Rusenov; Aneliya Milanova
Journal:  Antibiotics (Basel)       Date:  2021-03-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.